1. Home
  2. PHIN vs SPRY Comparison

PHIN vs SPRY Comparison

Compare PHIN & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHIN
  • SPRY
  • Stock Information
  • Founded
  • PHIN 2023
  • SPRY 2015
  • Country
  • PHIN United States
  • SPRY United States
  • Employees
  • PHIN N/A
  • SPRY N/A
  • Industry
  • PHIN
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • PHIN
  • SPRY Health Care
  • Exchange
  • PHIN Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • PHIN 2.0B
  • SPRY 1.8B
  • IPO Year
  • PHIN N/A
  • SPRY N/A
  • Fundamental
  • Price
  • PHIN $55.55
  • SPRY $14.47
  • Analyst Decision
  • PHIN Buy
  • SPRY Strong Buy
  • Analyst Count
  • PHIN 5
  • SPRY 4
  • Target Price
  • PHIN $54.60
  • SPRY $28.75
  • AVG Volume (30 Days)
  • PHIN 466.4K
  • SPRY 1.5M
  • Earning Date
  • PHIN 07-24-2025
  • SPRY 08-13-2025
  • Dividend Yield
  • PHIN 1.95%
  • SPRY N/A
  • EPS Growth
  • PHIN 59.07
  • SPRY N/A
  • EPS
  • PHIN 2.56
  • SPRY N/A
  • Revenue
  • PHIN $3,358,000,000.00
  • SPRY $112,339,000.00
  • Revenue This Year
  • PHIN $0.12
  • SPRY N/A
  • Revenue Next Year
  • PHIN $2.00
  • SPRY $170.64
  • P/E Ratio
  • PHIN $21.64
  • SPRY N/A
  • Revenue Growth
  • PHIN N/A
  • SPRY 22367.80
  • 52 Week Low
  • PHIN $36.25
  • SPRY $10.00
  • 52 Week High
  • PHIN $57.23
  • SPRY $18.90
  • Technical
  • Relative Strength Index (RSI)
  • PHIN 71.09
  • SPRY 29.63
  • Support Level
  • PHIN $48.94
  • SPRY $15.90
  • Resistance Level
  • PHIN $56.29
  • SPRY $18.63
  • Average True Range (ATR)
  • PHIN 1.40
  • SPRY 0.93
  • MACD
  • PHIN 0.33
  • SPRY -0.38
  • Stochastic Oscillator
  • PHIN 88.84
  • SPRY 3.59

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, the company generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: